DocDollars

Orexo Us, Inc.

NJ · United States · Reporting entity ID 100000061290

Total reported 2019–2025
$3.95M
#785 of 2,960 reporting companies — 0% of all reported industry payments
$331K in general payments across 17,205 records, plus $3.61M in research funding across 331 records.

How it breaks down

General payments $331,147
Research funding $3,614,006

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Orexo Us, Inc. reported $3.95M to US doctors and teaching hospitals from 2019 to 2025, ranking #785 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 17,205 general payment records and 331 research records were filed.

Common questions about Orexo Us, Inc.

How much has Orexo Us, Inc. paid US doctors?

Orexo Us, Inc. reported $3,945,152 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $331,147 in general payments, $3,614,006 in research funding.

How does Orexo Us, Inc. rank among drug and device companies?

It ranks #785 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Orexo Us, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.